| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 |
| filingDate |
2013-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_825efeeba0a11ad17dc61eba7e441e3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796de5d6df1b8d6ae4d7b9b3cfc55bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56020dbc63eb6d41c6f9513e80bfa91d |
| publicationDate |
2014-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014077096-A1 |
| titleOfInvention |
Method for preventing infections using combination of vector vaccine and live vaccine |
| abstract |
Provided is a method for preventing infections using a combination of a vector vaccine and a live vaccine. A recombinant vector virus (a vector vaccine) which is produced by integrating a DNA fragment encoding an infection-protective antigen derived from an animal infectious factor of a virus, a bacterium or the like into a virus genome by a gene recombination technique; an attenuated infectious factor (a live vaccine) which is produced by attenuating the infectious factor; a method for preventing infections in a non-human animal, which is characterized by using the vector vaccine and the live vaccine in combination; and a vaccine which is characterized by being produced using the vector vaccine and the live vaccine as active ingredients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021029385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019509260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7233928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019510497-A |
| priorityDate |
2012-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |